Aptevo Therapeutics APVO Income Statement (2015-2026)

NASDAQ APVO
$2.76 +0.03 (+1.10%)
At close: Aug 20, 2026 · 4:00 PM EDT
1Y3Y5Y7Y10YAll
Download Data
Income Statement Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Revenue & cost
Revenue (Quarter)
3.10M3.67M3.11M
Cost of Revenue (Quarter)
Gross Profit (Quarter)
Operating items
Research & Development (Quarter)
4.37M4.54M4.87M3.87M4.48M4.67M4.17M5.46M3.89M3.59M3.75M3.64M3.10M3.88M3.63M3.33M4.04M3.54M3.92M3.70M
Selling, General & Administrative (Quarter)
3.48M3.16M3.86M3.70M3.31M3.01M3.59M2.72M2.67M2.79M3.23M2.38M2.11M2.50M2.85M2.90M3.57M2.46M2.91M2.75M
Other Operating Expenses (Quarter)
9.65M
Operating Expenses (Quarter)
7.85M7.71M8.72M7.56M7.78M7.68M7.76M8.18M6.56M6.38M6.98M6.02M5.21M6.38M6.48M6.23M7.61M6.00M6.84M6.44M
Operating Income (Quarter)
-4.75M-4.04M-5.61M-7.56M-7.78M-7.68M-7.76M-8.18M-6.56M-6.38M-6.98M-6.02M-5.21M-6.38M-6.48M-6.23M-7.61M-6.00M-6.84M-6.44M
EBIT (Quarter)
-4.75M-4.04M-5.61M-7.56M-7.78M-7.68M-7.76M-8.18M-6.56M-6.38M-6.98M-6.02M-5.21M-6.38M-6.48M-6.23M-7.61M-6.00M-6.84M-6.44M
Non-operating items
Interest & Investment Income (Quarter)
Other Non Operating Income (Quarter)
-2.33M-2.56M-2.26M39.45M-0.03M-41.21M-0.07M0.23M0.23M0.19M0.15M0.14M0.11M0.07M0.07M0.02M0.06M0.19M0.14M0.09M
Non Operating Income (Quarter)
Net income details
EBT (Quarter)
-6.01M-4.04M-5.93M-8.11M-8.56M-8.58M-7.87M-8.64M-7.36M-7.53M-7.33M-6.71M-6.25M-7.76M-6.82M-6.91M-8.64M-6.48M-7.18M-7.13M
Tax Provisions (Quarter)
Profit After Tax (Quarter)
-7.00M-6.27M-7.70M28.01M-7.64M-5.16M2.77M-7.95M-6.33M-6.20M-6.83M-5.88M-5.10M-6.31M-6.41M-6.20M-7.55M-5.81M-6.70M-6.36M
Income from Continuing Operations (Quarter)
-6.01M-4.04M-5.93M-8.11M-8.56M-8.58M-7.87M-8.64M-7.36M-7.53M-7.33M-6.71M-6.25M-7.76M-6.82M-6.91M-8.64M-6.48M-7.18M-7.13M
Income from Discontinued Operations (Quarter)
Consolidated Net Income (Quarter)
0.08M0.33M0.18M0.15M0.17M0.52M0.95M0.29M-6.82M-6.91M-8.64M-6.48M-7.18M-7.13M
Income towards Parent Company (Quarter)
0.08M0.33M0.18M0.15M0.17M0.52M0.95M0.29M-6.82M-6.91M-8.64M-6.48M-7.18M-7.13M
Net Income towards Common Stockholders (Quarter)
0.08M0.33M0.18M0.15M0.17M0.52M0.95M0.29M-5.10M-6.31M-6.41M-6.91M-9.03M-6.20M-6.79M-6.36M
Additional items
EPS (Basic) (Quarter)
0.01M0.04M0.02M0.02M0.02M0.06M0.08M0.01M-0.01M-0.01M-0.00M-168.58-40.13-19.66-6.41-5.31
EPS (Diluted) (Quarter)
0.01M0.04M0.02M0.02M0.02M0.06M0.08M0.01M-0.01M-0.01M-0.00M-168.58-40.13-19.66-6.41-5.31
Shares Outstanding (Quarter)
8.008.008.009.009.009.0012.0011.0021.0021.0052.00264.00792.00767.000.00M0.04M0.22M0.32M1.06M1.20M
Shares Outstanding (Diluted) (Quarter)
8.008.008.009.009.009.0012.0011.0021.0021.0052.00264.00792.00767.000.00M0.04M0.22M0.32M1.06M1.20M
Shares Outstanding (Entity) (Quarter)
8.008.009.009.009.009.0012.0013.0025.0021.0051.00306.00792.00767.000.00M0.04M0.22M0.32M1.20M1.20M
EBITDA (Quarter)
-4.75M-4.04M-5.61M-7.56M-7.78M-7.68M-7.76M-8.18M-6.56M-6.38M-6.98M-6.02M-5.21M-6.38M-6.48M-6.23M-7.61M-6.00M-6.84M-6.44M
Interest Expenses (Quarter)
1.26M0.32M0.55M0.78M0.90M0.12M0.46M0.80M1.15M0.34M0.69M1.03M1.38M0.34M0.69M1.03M0.49M0.34M0.69M
Tax Rate (Quarter)